Report Overview
-
Request a Free Sample to learn more about this report
The global tissue processors market size was USD 235.8 million in 2022. As per our research, the market is expected to reach USD 325.1 million by 2028, exhibiting a CAGR of 10.0% during the forecast period. The COVID-19 pandemic has been unprecedented and staggering, with the tissue processors market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels.
The steps in tissue processing are what are needed to get fixed animal or human tissue to the point where a suitable histological wax can be implanted on the microtome and is prepared for section cutting. Tissue processing entails removing the water from the cells and replacing it with a media that freezes in order to produce thin slices on a microtome. After being properly repaired, tissue passes through three processes: dehydration, cleansing, and infiltration.
With cancer prevalence on the rise, there is a greater need for diagnostic screening for the disease. As a result, diagnostic centers for oncology and other related illnesses have seen a significant rise. The growing need for tissue samples in these facilities has led to an expansion of the tissue processors market growth. Additionally, the market has grown as a result of the growing application of histopathology in the analysis and diagnosis of tissue samples for a variety of illnesses. This has augmented the tissue processor market shares and revenue systems.
COVID-19 Impact- Imposed Lockdowns Significantly Affected the Global Market
Practically every business has been impacted by COVID-19, a global public health emergency, and many end-use industries are projected to experience growth during the forecast period as a result of the long-term repercussions. The framework is broadened by this study to take into account key COVID-19 considerations and possible next actions. Insights on COVID-19 are provided in the report, taking into account shifts in consumer demand and behavior, shopping habits, supply chain rerouting, the dynamics of current market forces, and key government efforts.
Latest Trends
"Hospitals to be a Great End-User for Market Expansion"
The need for tissue processing systems is growing as a result of technological advancements, an increase in lab usage of these systems to boost productivity, and easier access to sophisticated tissue processors.
Segmentation
-
Request a Free Sample to learn more about this report
● By Type Analysis
According to type, the market can be segmented into Desktop and Floor-standing amongst which Desktop is the leading segment.
● By Application Analysis
Based on application, the market can be divided into Hospital, Laboratory, and Other amongst which Hospital is the leading segment.
Driving Factors
"Increasing in the Use of Tissue transplant to Create Demand for the Product"
As cancer cases increase globally, the sector is expected to grow quicker. The population is ageing, lifestyle illnesses are on the rise, technology is advancing, and there are more government initiatives to give affordable, high-quality healthcare solutions. All of these factors are expected to contribute to the tissue process market expanding.
"Oncology To Amplify The Market Growth"
The demand for tissue diagnostics goods and services temporarily decreased as a result of the epidemic. But as things got better and healthcare systems adjusted to the new normal, the market started to rebound. The post-pandemic period saw a continued high demand for tissue diagnostics due to the necessity for reliable diagnosis and surveillance of numerous disorders, including cancer. Anatomic pathology has undergone a paradigm shift as a result of the sharp rise in cancer incidence. The area of clinical pathology is thus continuing to expand as a result of this.
Restraining Factors
"High Installations Costs to Limit Market Growth"
The tissue processing system's tight rules and restrictions will slow the market's expansion. The rules are to be strictly followed as the tissue processing is an expensive medical treatment which makes the process quite lengthy and is anticipated to impede the tissue processor market growth.
Regional Insights
-
Request a Free Sample to learn more about this report
"North America to Lead the Market Owing to a High Demand for Cancer Treatment Facilities"
Because of the high incidence of cancer, North America dominated the tissue processors market share. Numerous government initiatives are in place with the goal of reducing cancer rates and increasing the demand for cancer diagnosis in the local market. A key initiative of the Centres for Disease Control and Prevention that concentrates on cancer prevention in this area is the Cancer Prevention and Control Research Network. The utilization of human tissue in the creation of cutting-edge testing is crucial to personalized treatment. Tissue diagnostics are increasingly used as a result of the expansion of personalized medicine brought about by the increased use of sequencing technologies and healthcare IT systems in clinical workflow. North America's personalised medicine market is continuing to rise thanks to the U.S.'s Precision Medicine Initiative.
Key Industry Players
"Key Players Focus on Partnerships to Sustain in the Market"
Plastic sorters competitors make coalitions and collaborate to get a competitive advantage. By collaborating with other companies, they intend to capitalize on complementary strengths and broaden their market reach. Companies also invest in R&D to bring new and innovative products to market. Furthermore, major corporations are exploring mergers and acquisitions to broaden their product lines and strengthen their market position.
List of Market Players Profiled
- Leica Biosystems (Germany)
- Thermo Fisher Scientific (U.S.)
- Sakura Finetek (Japan)
- Milestone Medical (U.S.)
- Dakewe (China)
Report Coverage
This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.
| REPORT COVERAGE | DETAILS |
|---|---|
Market Size Value In |
US$ 235.8 Million in 2021 |
Market Size Value By |
US$ 325.1 Million by 2028 |
Growth Rate |
CAGR of 5.5% from 2021 to 2028 |
Forecast Period |
2022-2028 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
What value is the global Tissue Processors Market expected to touch by 2028?
The global Tissue Processors Market is expected to reach USD 32.5 million by 2028.
-
What CAGR is the Tissue Processors Market expected to exhibit by 2028?
The Tissue Processors Market is expected to exhibit a CAGR of 10.0% by 2028.
-
What are the driving factors of the market?
Increasing in the Use of Tissue transplant along with Oncology are the major driving factors
-
Which are the key players or most dominating companies functioning in the market?
Leica Biosystems (Germany), Thermo Fisher Scientific (U.S.), Sakura Finetek (Japan), Milestone Medical (U.S.), and Dakewe (China) are some of the noticeable key players.
